Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.30

Mkt cap

1.6B

Volume

197K

High

2.30

P/E Ratio

-7.03

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

2.07

Pablo Zuanic forecasts Germany's medical cannabis market to grow to €1.7 billion by 2025, driven by legislative changes and increased accessibility. Canadian companies Aurora (ACB) and Tilray (TLRY), along with Curaleaf (CURLF) through its German subsidiary Four20 Pharma, are well-positioned to benefit from this growth. The introduction of cannabis social clubs and easier prescription processes are key growth drivers.

Portfolio Pulse from Nicolás Jose Rodriguez

February 28, 2024 | 3:45 pm

The U.S. Cannabis Council (USCC) and Curaleaf Holdings Inc. (OTCQX:CURLF) have initiated a national donation drive across nearly 140 Curaleaf dispensaries to support cannabis legalization in the U.S. The campaign encourages customers to round up their purchases for donations, with plans to expand to dispensaries operated by MariMed Inc. (OTCQX:MRMD) and others. Funds raised will support the USCC's legislative advocacy efforts, including the capacity to support or oppose political candidates, as part of a broader strategy to achieve federal cannabis legalization.

Portfolio Pulse from Patricio Liddle

February 26, 2024 | 10:21 pm

Following Germany's decision to legalize limited cannabis possession, U.S. and Canadian cannabis stocks like Curaleaf Holdings, Trulieve Cannabis Corp., Green Thumb Industries, Cresco Labs, Tilray, and Aurora Cannabis saw movements in their stock prices. Analysts predict significant growth potential in the German market, comparing it to Florida's medical cannabis market. Companies like Tilray and Aurora Cannabis, already established in Germany, are well-positioned to benefit. Curaleaf's affiliate owns a German importer, and High Tide Inc. expressed enthusiasm about entering the German market.

Portfolio Pulse from Maureen Meehan

February 26, 2024 | 9:13 pm

The article discusses the expectations for EBITDA growth among the largest MSOs in the cannabis industry for Q3:23, Q4:23, and the full year 2024. It highlights that sequential quarter growth was negative for ten out of twelve companies, with an overall projected EBITDA decrease of 5.9% from Q3 to Q4:23. However, year-over-year growth is expected to be stronger among smaller companies. The departure of major companies from several markets is noted, with a focus on concentrating on more profitable markets as a key driver for potential better-than-expected performance in 2024. The expected growth in 2024 EBITDA is 13.4%, driven by modest revenue growth and an increase in EBITDA margins. The article suggests that analysts might be underestimating the potential for 2024 due to continuous downward revisions in 2023.

Portfolio Pulse from Viridian Capital Advisors

February 26, 2024 | 6:41 pm

Germany's legalization of limited cannabis possession and consumption has positively impacted U.S. cannabis stocks, with Curaleaf Holdings seeing a 3.1% rise. The move is seen as a step towards broader European legalization, benefiting companies with a presence in Germany like Curaleaf. Other U.S. cannabis stocks also saw gains, while Canadian companies Tilray and Aurora Cannabis had mixed results. The industry views this as a significant opportunity for growth, especially in medical cannabis.

Portfolio Pulse from Maureen Meehan

February 24, 2024 | 5:26 pm

Jushi Holdings (OTC:JUSHF) is highlighted by analyst Pablo Zuanic as having significant upside potential in the cannabis market, particularly in Pennsylvania and Virginia due to regulatory shifts. The company's current undervaluation and strategic positioning, including debt management and market expansion, suggest a positive outlook. Zuanic projects a substantial market cap increase for Jushi, outpacing competitors like AYR (OTC:AYRWF), Cresco (OTC:CRLBF), and TerrAscend (OTC:TSNDF), especially if recreational sales commence in these states. Despite challenges, Jushi's operational efficiencies and financial maneuvers indicate resilience and potential for growth.

Portfolio Pulse from Nicolás Jose Rodriguez

February 21, 2024 | 7:35 pm

Zuanic & Associates initiated coverage of Jushi Holdings Inc. with an Overweight rating, citing its undervaluation and strategic positioning in the cannabis sector. The firm highlights Jushi's potential for significant growth, especially with the anticipated shift to recreational cannabis sales in Pennsylvania and Virginia. The analysis also compares Jushi's valuation to other key players in the industry, such as Green Thumb Industries and Curaleaf Holdings, and discusses the broader competitive landscape. Additionally, the report touches on the potential for industry consolidation and Jushi's financial resilience.

Portfolio Pulse from Nicolás Jose Rodriguez

February 21, 2024 | 1:59 pm

Nevada's first cannabis consumption lounge, Smoke and Mirrors, has opened in Las Vegas, marking a significant milestone for the state's cannabis industry. Located within Thrive Cannabis Marketplace, it's the first to pass the Nevada Cannabis Compliance Board inspection. This development is expected to boost Nevada's cannabis market, valued at $850 million, by attracting tourists, creating jobs, and increasing tax revenue. Planet 13 Holdings Inc. (PLNHF) has also announced plans to integrate a consumption lounge, indicating a growing trend. Other notable companies in Nevada's cannabis sector include AYR Wellness (AYRWF), Curaleaf Holdings (CURLF), and Green Thumb Industries (GTBIF).

Portfolio Pulse from Nicolás Jose Rodriguez

February 16, 2024 | 9:28 pm

California's AB 2223, introduced by Assembly Member Cecilia Aguiar-Curry, aims to revolutionize the state's cannabis and hemp sectors by allowing cannabis licensees to sell or incorporate products containing industrial hemp, subject to strict regulatory oversight. The bill seeks to establish a clear definition of "synthetically derived cannabinoid" and proposes stringent THC thresholds for hemp-derived products. This legislation could significantly impact California-based cannabis companies by expanding the marketplace while ensuring product safety and legal integrity.

Portfolio Pulse from Patricio Liddle

February 13, 2024 | 9:43 pm

As Super Bowl LVIII approaches in Las Vegas, Nevada's cannabis industry is poised to benefit from increased visitor traffic, thanks to legislative reforms and strategic market positioning. The state has raised legal possession limits and removed medical license requirements for retailers. Nevada's cannabis market, valued at $850 million, is stabilizing with slight sales fluctuations but overall strong economic indicators. The market features 104 dispensaries with high revenue per store and wholesale prices. Leading brands and public multi-state operators (MSOs) like AYR Wellness, Curaleaf Holdings, Green Thumb Industries, and Planet 13 Holdings are key players. Planet 13 stands out for maintaining its market share and enhancing customer experience with innovative offerings.

Portfolio Pulse from Nicolás Jose Rodriguez

February 09, 2024 | 8:58 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.